Spinal Devices and Biologics Market in the US 2011-2015

TechNavio's analysts forecast the Spinal Devices and Biologics market in the US to grow at a CAGR of 1.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The Spinal Devices and Biologics market in the US has also been witnessing increasing popularity of minimally invasive surgery. However, the reduction in reimbursements for spinal procedures could pose a challenge to the growth of this market.

TechNavio's report, the Spinal Devices and Biologics Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses the US market; it also covers the Spinal Devices and Biologics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Depuy Inc., Medtronic Inc., NuVasive Inc., Stryker Corp., and Synthes Inc.

Other vendors mentioned in the report: Abbott Laboratories, Alphatec Spine Inc., Amedica Corp., Biomet Inc., Blackstone Medical Inc., Cervitech Inc., Facet Solutions Inc., Globus Medical Inc., Integra Lifesciences Corp., NuVasive Inc., Orthofix International NV, Orthovita Inc., Osteotech Inc., Scient'x Groupe SAS (Alphatec), SeaSpine Inc. (Integra), and Zimmer Inc.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
04.1 Market Size and Forecast of Spinal Devices and Biologics Market in the US
04.2 Categories of Products in the Spinal Devices and Biologics Market in the US
Market Share by Key Product
04.3 Key Market Segments
04.4 Market Share by Key Segments
04.5 Key Applications
04.6 Five Forces Analysis
05. Vendor Landscape
05.1 Product Portfolio Matrix of Leading Vendors in the Market
05.2 Vendor Landscape of Spinal Devices and Biologics Market in the US
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
Impact of Drivers on End-user Category
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Key Vendor Analysis
12.1 Medtronic Inc.
Business Overview
SWOT Analysis
12.2 DePuy Inc.
Business Overview
SWOT Analysis
12.3 Synthes Inc.
Business Overview
SWOT Analysis
12.4 NuVasive Inc.
Business Overview
SWOT Analysis
12.5 Stryker Corp.
Business Overview
SWOT Analysis
13. Other Reports in this Series

List of Exhibits:
Exhibit 1: Spinal Devices and Biologics Market in the US 2011-2015 (US$ million)
Exhibit 2: Categories of Products in the Spinal Devices and Biologics Market in the US
Exhibit 3: Spinal Devices and Biologics Market in the US by Share of Key Product 2011
Exhibit 4: Spinal Devices and Biologics Market in the US by Market Segmentation
Exhibit 5: Spinal Devices and Biologics Market in US by Market Share of Key Market Segments 2011
Exhibit 6: Spinal Devices and Biologics Market in the US by Key Applications 2011 (percent)
Exhibit 7: Spinal Devices and Biologics Market in the US by Vendor Segmentation 2011
Exhibit 8: Business Segmentation of Medtronic Inc.